» Articles » PMID: 28322152

Serotonin Receptor Binding Characteristics of Geissoschizine Methyl Ether, an Indole Alkaloid in Uncaria Hook

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2017 Mar 22
PMID 28322152
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Geissoschizine methyl ether (GM) is one of the indole alkaloids in Uncaria hook, and an active ingredient of yokukansan (YKS) that improves behavioral and psychological symptoms of dementia (BPSD) in patients with several types of dementia. The pharmacological action of GM has been related to various serotonin (5-HT) receptor subtypes.

Objective: The aim of this article is to review the binding characteristics of GM to the 5-HT receptor subtypes in the brains using our own data and previous findings.

Method: Competitive receptor-binding and agonist/antagonist activity assays for several 5-HT receptor subtypes were performed. Moreover, the articles describing pharmacokinetics and brain distribution of GM were searched in PubMed.

Results: GM bound the following 5-HT receptor subtypes: 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT2C, 5- HT4, 5-HT5A, 5-HT6, and 5-HT7. Among these receptors, GM had partial agonistic activity for 5-HT1A receptors and antagonistic activity for 5-HT2A, 5-HT2B, 5-HT2C, and 5-HT7 receptors. Also, GM was metabolized by various CYP isoforms, mainly CYP3A4. Parent/unchanged GM was detected in both the blood and brain of rats after oral administration of YKS. In the brains, GM was presumed to bind to 5- HT1A, 5-HT2A, 5-HT2B, 5-HT2C, and 5-HT7 receptors on neuron-like large cells mainly in the frontal cortex.

Conclusion: These results suggest that GM is a pharmacologically important alkaloid that regulates various serotonergic activities or functions by binding to multiple 5-HT receptor subtypes. Thus, this review provides recent 5-HT receptor-related evidence that GM is partly responsible for pharmacological effects of YKS.

Citing Articles

Successful treatment with traditional Japanese medicine (kampo medicine) Yokukansan as a migraine prophylactic drug: A case report.

Akiyama H, Hasegawa Y, Yamano Y Medicine (Baltimore). 2024; 103(30):e39072.

PMID: 39058870 PMC: 11272254. DOI: 10.1097/MD.0000000000039072.


The Serotonin-Mediated Anti-Allodynic Effect of Yokukansan on Paclitaxel-Induced Neuropathic Pain.

Yokomi H, Kato T, Narasaki S, Kamiya S, Taguchi S, Horikawa Y Medicina (Kaunas). 2024; 60(3).

PMID: 38541085 PMC: 10972347. DOI: 10.3390/medicina60030359.


Quantitative imaging of natural products in fine brain regions using desorption electrospray ionization mass spectrometry imaging (DESI-MSI): Uncaria alkaloids as a case study.

Gao L, Zhang Z, Wu W, Deng Y, Zhi H, Long H Anal Bioanal Chem. 2022; 414(17):4999-5007.

PMID: 35639139 DOI: 10.1007/s00216-022-04130-3.


Activity of ("Kratom") Alkaloids at Serotonin Receptors.

Leon F, Obeng S, Mottinelli M, Chen Y, King T, Berthold E J Med Chem. 2021; 64(18):13510-13523.

PMID: 34467758 PMC: 9235362. DOI: 10.1021/acs.jmedchem.1c00726.


Properties, Pharmacology, and Pharmacokinetics of Active Indole and Oxindole Alkaloids in Hook.

Kushida H, Matsumoto T, Ikarashi Y Front Pharmacol. 2021; 12:688670.

PMID: 34335255 PMC: 8317223. DOI: 10.3389/fphar.2021.688670.


References
1.
Martin G, Humphrey P . Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology. 1994; 33(3-4):261-73. DOI: 10.1016/0028-3908(94)90058-2. View

2.
Qin K, Sethi P, Lambert N . Abundance and stability of complexes containing inactive G protein-coupled receptors and G proteins. FASEB J. 2008; 22(8):2920-7. PMC: 2493464. DOI: 10.1096/fj.08-105775. View

3.
Shultz S, Worzella T, Gallagher A, Shieh J, Goueli S, Hsiao K . Miniaturized GPCR signaling studies in 1536-well format. J Biomol Tech. 2009; 19(4):267-74. PMC: 2567138. View

4.
May J, McLaughlin M, Sharif N, Hellberg M, Dean T . Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther. 2003; 306(1):301-9. DOI: 10.1124/jpet.103.049528. View

5.
Saucier C, Albert P . Identification of an endogenous 5-hydroxytryptamine2A receptor in NIH-3T3 cells: agonist-induced down-regulation involves decreases in receptor RNA and number. J Neurochem. 1997; 68(5):1998-2011. DOI: 10.1046/j.1471-4159.1997.68051998.x. View